Polymeric Drug-Delivery Systems: Role in P-gp Efflux System Inhibition

Article Properties
Citations
Title Journal Journal Categories Citations Publication Date
Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer

Frontiers in Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
2 2022
Citations Analysis
The category Medicine: Therapeutics. Pharmacology 1 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer and was published in 2022. The most recent citation comes from a 2022 study titled Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer. This article reached its peak citation in 2022, with 1 citations. It has been cited in 1 different journals, 100% of which are open access. Among related journals, the Frontiers in Pharmacology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year